Development of vector-specific, resistance-breaking insecticides to reduce malari

开发病媒特异性、突破耐药性的杀虫剂以减少疟疾

基本信息

  • 批准号:
    8237040
  • 负责人:
  • 金额:
    $ 66.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Malaria exacts a terrible toll in sub-Saharan Africa, killing an estimated 1-2 million persons each year, mostly children. Pyrethroid-based insecticide treated nets (pyrethroid ITNs) provide the first line of defense against disease transmission, but emerging resistant strains of the disease vector (Anopheles gambiae) threaten to render these ITNs ineffective. Our broad objective is to develop a new class of acetylcholinesterase (AChE)-targeting insecticide for deployment on ITNs, that is safe for use, effective against current pyrethroid- and AChE- resistant strains, and is less likely to foster emergence of new AChE-resistant strains. Thus our goal is consistent with the focus of the solicitation on novel interventions for the control of Malaria. FNIH-sponsored research from 2005-2008 enabled us to make significant progress towards our long-term goal. Further support from NIH will allow us to establish proof of concept that our novel AChE-based insecticide, deployed on an ITN, would constitute a superior intervention to manage the disease vector. Thus our goal is also consistent with the stated aim of the solicitation to fund translational research. To achieve our goal we have assembled a team of chemists, structural biologists, entomologists, and toxicologists. Our specific aims are to 1)improve stability of An. gambiae AChE (AgAChE)-selective carbamates to oxidative detoxification; 2)acquire 3D structural information on AgAChE to optimize inhibition potency and selectivity; 3)develop bivalent carbamates for resilience to target-site mutation; 4)identify strategies to mitigate against carboxylesterase-mediated detoxification; and 5)make a preliminary assessment of mammalian toxicity of the most promising insecticides to emerge from these studies. To guide us through the proposed five years of research we have prepared a detailed timeline and decision tree that incorporate five integrated streams of insecticide discovery for optimizing field performance and human safety. Moreover the built-in complementarity of the chemical synthesis routes and the optimization approaches (e.g. resilience to both target-site and metabolic resistance mechanisms) means that unexpected difficulty in one stream need not slow progress in the other streams. These multiple approaches increase the probability of project success. Malaria exacts a terrible toll in sub-Saharan African, and at present the first line of defense against the mosquito vector of the disease is provided by insecticide treated nets (ITNs). However, growing resistance to the class of insecticide used on the nets threatens to make this protection ineffective. We propose to develop a new class of insecticide that is safe for ITN deployment, effective against current insecticide-resistant mosquitoes, and less likely to promote emergence of new resistant strains.
描述(由申请人提供):疟疾在撒哈拉以南非洲造成了可怕的损失,每年造成大约1- 200万人死亡,其中大多数是儿童。基于拟除虫菊酯的杀虫剂处理过的蚊帐(拟除虫菊酯蚊帐)提供了防止疾病传播的第一道防线,但是新出现的病媒(冈比亚按蚊)耐药菌株有可能使这些蚊帐失效。我们的主要目标是开发一类新的乙酰胆碱酯酶(AChE)靶向杀虫剂,用于ITNs部署,该杀虫剂使用安全,对现有的拟除虫菊酯和AChE耐药菌株有效,并且不太可能促进新的AChE耐药菌株的出现。因此,我们的目标与本次征集活动对控制疟疾的新干预措施的重点是一致的。从2005年到2008年,fnih赞助的研究使我们在实现长期目标方面取得了重大进展。美国国立卫生研究院的进一步支持将使我们能够建立概念证明,我们的新型基于乙酰氨基酚的杀虫剂,部署在ITN上,将构成管理病媒的优越干预措施。因此,我们的目标也与邀请资助转化研究的既定目标一致。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul R Carlier其他文献

Paul R Carlier的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul R Carlier', 18)}}的其他基金

Optimization of antimalarials targeting multiple life stages of the parasite
针对寄生虫多个生命阶段的抗疟药物的优化
  • 批准号:
    10745610
  • 财政年份:
    2021
  • 资助金额:
    $ 66.12万
  • 项目类别:
Optimization of antimalarials targeting multiple life stages of the parasite
针对寄生虫多个生命阶段的抗疟药物的优化
  • 批准号:
    10298005
  • 财政年份:
    2021
  • 资助金额:
    $ 66.12万
  • 项目类别:
Optimization of antimalarials targeting multiple life stages of the parasite
针对寄生虫多个生命阶段的抗疟药物的优化
  • 批准号:
    10813425
  • 财政年份:
    2021
  • 资助金额:
    $ 66.12万
  • 项目类别:
Optimization of antimalarials targeting multiple life stages of the parasite
针对寄生虫多个生命阶段的抗疟药物的优化
  • 批准号:
    10689033
  • 财政年份:
    2021
  • 资助金额:
    $ 66.12万
  • 项目类别:
Interrogating plasmodial endocytosis with mefloquine-based affinity probes
用基于甲氟喹的亲和探针检测疟原虫内吞作用
  • 批准号:
    10089405
  • 财政年份:
    2020
  • 资助金额:
    $ 66.12万
  • 项目类别:
MEDICINAL CHEMISTRY, CHEMICAL SYNTHESIS, AND MASS SPECTROMETRY
药物化学、化学合成和质谱分析
  • 批准号:
    8168768
  • 财政年份:
    2010
  • 资助金额:
    $ 66.12万
  • 项目类别:
MEDICINAL CHEMISTRY, CHEMICAL SYNTHESIS, AND MASS SPECTROMETRY
药物化学、化学合成和质谱分析
  • 批准号:
    7954019
  • 财政年份:
    2009
  • 资助金额:
    $ 66.12万
  • 项目类别:
Development of vector-specific, resistance-breaking insecticides to reduce malari
开发病媒特异性、突破耐药性的杀虫剂以减少疟疾
  • 批准号:
    8445236
  • 财政年份:
    2009
  • 资助金额:
    $ 66.12万
  • 项目类别:
Development of vector-specific, resistance-breaking insecticides to reduce malari
开发针对病媒的抗药性杀虫剂以减少疟疾
  • 批准号:
    7657602
  • 财政年份:
    2009
  • 资助金额:
    $ 66.12万
  • 项目类别:
Development of vector-specific, resistance-breaking insecticides to reduce malari
开发针对病媒的抗药性杀虫剂以减少疟疾
  • 批准号:
    7796794
  • 财政年份:
    2009
  • 资助金额:
    $ 66.12万
  • 项目类别:

相似海外基金

Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease
乙酰胆碱酯酶抑制剂对患有轻至中度阿尔茨海默病的老年人骨代谢和骨折危险因素的影响
  • 批准号:
    10739853
  • 财政年份:
    2023
  • 资助金额:
    $ 66.12万
  • 项目类别:
ACETYLCHOLINESTERASE INHIBITORS AND DEMENTIAS
乙酰胆碱酯酶抑制剂和痴呆症
  • 批准号:
    2049152
  • 财政年份:
    1993
  • 资助金额:
    $ 66.12万
  • 项目类别:
ACETYLCHOLINESTERASE INHIBITORS AND DEMENTIAS
乙酰胆碱酯酶抑制剂和痴呆症
  • 批准号:
    2049153
  • 财政年份:
    1992
  • 资助金额:
    $ 66.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了